Akouos

Akouos is a pre-clinical company developing a pipeline of Anc80 AAV-based gene therapies for hearing disorders.
Domain
Healthcare
Status
IPO’d/​Acquired
Acquisition Announcement Date
2022
IPO Date
2020
Stage of Initial Investment
Series A
Initial Investment Year
2018
Akouos Port Co Hover Image sm